“…AHR 10718 is an investigational class I antiarrhythmic drug and was effective on digitalis and coronary ligation arrhythmias, but was not effective on adrenaline arrhythmia [20], and the recalculated ICs0s for digitalis, 24-hour coronary ligation, and adrenaline arrhythmias were 3.8 (3.0-5.9; n = 31, r = -0.57, p < 0.01), 9.0 (5.8-30; n = 22, r = -0.51, p < 0.05), and 18.9 (13.3-60; n = 20, r = -0.52, p < 0.05) ~g/ ml. AN-132 is also an investigational class I antiarrhythmic drug and was effective on digitalis and coronary ligation arrhythmias, but was not effective on adrenaline arrhythmia [28], and the recalculated ICs0s for digitalis, 24-hour coronary ligation, and adrenaline arrhythmias were 1.6 (1.0-4.3; n = 22, r = -0.52, p < 0.05), 8.3 (4.3-~; n = 30, r = -0.38, p < 0.05), and 10.6 (8.0-19.5; n = 28, r = -0.41, p < 0.01) ~g/ml.…”